Actinobacteria and Myxobacteria : Important Resources for Novel Antibiotics
Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the w...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (270 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545572004498 |
|---|---|
| ctrlnum |
(CKB)5400000000043471 (oapen)https://directory.doabooks.org/handle/20.500.12854/69411 (EXLCZ)995400000000043471 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Wink, Joachim edt Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics Actinobacteria and Myxobacteria Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (270 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units. English Research & information: general bicssc Biology, life sciences bicssc actinomycetes antibiotic biosynthesis silent biosynthetic pathways γ-butyrolactones HiTES translation inhibitors marine actinobacteria Streptomyces sp. enzyme inhibition antimicrobial antioxidant cytotoxicity GC-MS pyrrolopyrazines myxobacteria antivirals secondary metabolites HIV Ebola hepatitis viruses diversity uncultured new antibiotics Streptomyces polyketides secondary metabolite polyketide synthases (PKSs) 3-03943-529-9 3-03943-530-2 Wink, Joachim oth |
| language |
English |
| format |
eBook |
| author2 |
Wink, Joachim |
| author_facet |
Wink, Joachim |
| author2_variant |
j w jw |
| author2_role |
Sonstige |
| title |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| spellingShingle |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| title_sub |
Important Resources for Novel Antibiotics |
| title_full |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| title_fullStr |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| title_full_unstemmed |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| title_auth |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| title_alt |
Actinobacteria and Myxobacteria |
| title_new |
Actinobacteria and Myxobacteria |
| title_sort |
actinobacteria and myxobacteria important resources for novel antibiotics |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2020 |
| physical |
1 electronic resource (270 p.) |
| isbn |
3-03943-529-9 3-03943-530-2 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT winkjoachim actinobacteriaandmyxobacteriaimportantresourcesfornovelantibiotics AT winkjoachim actinobacteriaandmyxobacteria |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000043471 (oapen)https://directory.doabooks.org/handle/20.500.12854/69411 (EXLCZ)995400000000043471 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796649061972967424 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02516nam-a2200649z--4500</leader><controlfield tag="001">993545572004498</controlfield><controlfield tag="005">20231214133408.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043471</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69411</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043471</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wink, Joachim</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Actinobacteria and Myxobacteria</subfield><subfield code="b">Important Resources for Novel Antibiotics</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Actinobacteria and Myxobacteria</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (270 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">actinomycetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic biosynthesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">silent biosynthetic pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">γ-butyrolactones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HiTES</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">translation inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marine actinobacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Streptomyces sp.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enzyme inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antioxidant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GC-MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pyrrolopyrazines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myxobacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antivirals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">secondary metabolites</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Ebola</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis viruses</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diversity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uncultured</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">new antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Streptomyces</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyketides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">secondary metabolite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyketide synthases (PKSs)</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-529-9</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-530-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wink, Joachim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:52:49 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337984120004498&Force_direct=true</subfield><subfield code="Z">5337984120004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337984120004498</subfield></datafield></record></collection> |